These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 2004104)

  • 21. [Effect of membrane modification by PEG on prolongation of circulation time of liposomes in blood in vivo].
    Hou XP; Zhang JM; Lu XD
    Yao Xue Xue Bao; 1996; 31(6):451-4. PubMed ID: 9275724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Large liposomes containing ganglioside GM1 accumulate effectively in spleen.
    Liu D; Mori A; Huang L
    Biochim Biophys Acta; 1991 Jul; 1066(2):159-65. PubMed ID: 1854781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sterically stabilized liposomes.
    Woodle MC; Lasic DD
    Biochim Biophys Acta; 1992 Aug; 1113(2):171-99. PubMed ID: 1510996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of chemically modified GM1 and neoglycolipid analogs of GM1 on liposome circulation time: evidence supporting the dysopsonin hypothesis.
    Park YS; Huang L
    Biochim Biophys Acta; 1993 Feb; 1166(1):105-14. PubMed ID: 8431484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups.
    Torchilin VP; Levchenko TS; Lukyanov AN; Khaw BA; Klibanov AL; Rammohan R; Samokhin GP; Whiteman KR
    Biochim Biophys Acta; 2001 Apr; 1511(2):397-411. PubMed ID: 11286983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo.
    Allen TM; Hansen C; Martin F; Redemann C; Yau-Young A
    Biochim Biophys Acta; 1991 Jul; 1066(1):29-36. PubMed ID: 2065067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel liposome surface modification agent that prolongs blood circulation and retains surface ligand reactivity.
    Ishihara A; Yamauchi M; Tsuchiya T; Mimura Y; Tomoda Y; Katagiri A; Kamiya M; Nemoto H; Suzawa T; Yamasaki M
    J Biomater Sci Polym Ed; 2012; 23(16):2055-68. PubMed ID: 22054261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids.
    Bradley AJ; Devine DV; Ansell SM; Janzen J; Brooks DE
    Arch Biochem Biophys; 1998 Sep; 357(2):185-94. PubMed ID: 9735159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes.
    Liu D; Mori A; Huang L
    Biochim Biophys Acta; 1992 Feb; 1104(1):95-101. PubMed ID: 1550858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of antibody-mediated elimination of ligand-targeted liposomes by using poly(ethylene glycol)-modified lipids.
    Li WM; Mayer LD; Bally MB
    J Pharmacol Exp Ther; 2002 Mar; 300(3):976-83. PubMed ID: 11861806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening effect of PEG on avidin binding to liposome surface receptors.
    Kaasgaard T; Mouritsen OG; Jørgensen K
    Int J Pharm; 2001 Feb; 214(1-2):63-5. PubMed ID: 11282238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterisation of biotinylated liposomes for in vivo targeting applications.
    Loughrey HC; Ferraretto A; Cannon AM; Acerbis G; Sudati F; Bottiroli G; Masserini M; Soria MR
    FEBS Lett; 1993 Oct; 332(1-2):183-8. PubMed ID: 8405439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation of long-circulating immunoliposomes containing adriamycin by a novel method to coat immunoliposomes with poly(ethylene glycol).
    Suzuki S; Watanabe S; Masuko T; Hashimoto Y
    Biochim Biophys Acta; 1995 Aug; 1245(1):9-16. PubMed ID: 7654771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation of long-circulating immunoliposomes using PEG-cholesterol conjugates: effect of the spacer arm between PEG and cholesterol on liposomal characteristics.
    Carrion C; Domingo JC; de Madariaga MA
    Chem Phys Lipids; 2001 Nov; 113(1-2):97-110. PubMed ID: 11687230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of molecular weight in amphipathic polyethyleneglycol on prolonging the circulation time of large unilamellar liposomes.
    Maruyama K; Yuda T; Okamoto A; Ishikura C; Kojima S; Iwatsuru M
    Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1620-2. PubMed ID: 1934187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of in vivo immunoliposome targeting to pulmonary endothelium.
    Maruyama K; Holmberg E; Kennel SJ; Klibanov A; Torchilin VP; Huang L
    J Pharm Sci; 1990 Nov; 79(11):978-84. PubMed ID: 2292774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of lipid composition on incorporation of trastuzumab-PEG-lipid into nanoliposomes by post-insertion method: physicochemical and cellular characterization.
    Golkar N; Tamaddon AM; Samani SM
    J Liposome Res; 2016; 26(2):113-25. PubMed ID: 26023889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo.
    Torchilin VP; Shtilman MI; Trubetskoy VS; Whiteman K; Milstein AM
    Biochim Biophys Acta; 1994 Oct; 1195(1):181-4. PubMed ID: 7918561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attenuated polyethylene glycol immunogenicity and overcoming accelerated blood clearance of a fully PEGylated dendrimer.
    Kojima C; Yao J; Nakajima K; Suzuki M; Tsujimoto A; Kuge Y; Ogawa M; Matsumoto A
    Int J Pharm; 2024 Jun; 659():124193. PubMed ID: 38703934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PEG-immunoliposome.
    Maruyama K
    Biosci Rep; 2002 Apr; 22(2):251-66. PubMed ID: 12428903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.